deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00781118

AngelMed for Early Recognition and Treatment of STEMI (ALERTS)

Sponsor: Angel Medical Systems

Conditions Acute Coronary Syndrome Acute Myocardial Infarction (AMI) Coronary Occlusion
Interventions Guardian System
Updated 9 times since 2017 Last updated: Mar 9, 2018 Started: Dec 31, 2008 Primary completion: May 1, 2014 Completion: May 17, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00781118, this PHASE3 trial focuses on Acute Coronary Syndrome and Acute Myocardial Infarction (AMI) and remains completed. Sponsored by Angel Medical Systems, it has been updated 9 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotActive Not Recruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotCompleted~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jan 2021 — Apr 2022 [monthly]

    Completed PHASE3

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  2. Mar 2018 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  3. Feb 2017 — Mar 2018 [monthly]

    Active Not Recruiting PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Angel Medical Systems
  • Symbios Clinical
Data source: Angel Medical Systems

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Amarillo, United States , Anderson, United States , Baltimore, United States , Bay City, United States , Bay Pines, United States , Bethesda, United States , Birmingham, United States , Bloomington, United States , Brooklyn, United States and 78 more locations